“Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S40. doi:10.25251/skin.3.supp.40.